Other variables, including age, sex, BMI, hypertension, and use of RAAS inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, and statins, were not significantly associated with rapid progression after adjustment (Figure 2). This evidence concerns the gene GLP1R and Hypertension.